Status:
COMPLETED
Reconstructive Management of Peri-implantitis
Lead Sponsor:
Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain
Conditions:
Resolution of Pathologic Process
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
With the growing burden of peri-implantitis around the globe, interest has flourished on the management of this pathology. Nevertheless, lack of consensus exists in the pursuit of a predictable therap...
Detailed Description
The effect of barrier membrane in the reconstructive management of peri-implantitis will be tested at 12-month follow-up
Eligibility Criteria
Inclusion
- Non-smokers
- No use of antibiotics recently
- No metabolic disorder
- Infra-osseous or combined peri-implantitis defect
Exclusion
- Smokers
- Pregnant
- Metabolic disorders that affect bone healing
- Supra-crestal defects
Key Trial Info
Start Date :
March 27 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 16 2022
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT05282667
Start Date
March 27 2019
End Date
November 16 2022
Last Update
December 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica CICOM
Badajoz, Spain, 06011